alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 88, Number 208 (Monday, October 30, 2023)]
[Notices]
[Page 74150]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23851]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Order No. 2149]


Reorganization and Expansion of Foreign-Trade Zone 255 Under 
Alternative Site Framework; Washington County, Maryland

    Pursuant to its authority under the Foreign-Trade Zones Act of June 
18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade Zones Board 
(the Board) adopts the following Order:
    Whereas, the Foreign-Trade Zones (FTZ) Act provides for ``. . . the 
establishment . . . of foreign-trade zones in ports of entry of the 
United States, to expedite and encourage foreign commerce, and for 
other purposes,'' and authorizes the Board to grant to qualified 
corporations the privilege of establishing foreign-trade zones in or 
adjacent to U.S. Customs and Border Protection ports of entry;
    Whereas, the Board adopted the alternative site framework (ASF) (15 
CFR 400.2(c)) as an option for the establishment or reorganization of 
zones;
    Whereas, the Board of County Commissioners of Washington County, 
grantee of Foreign-Trade Zone 255, submitted an application to the 
Board (FTZ Docket B-27-2023, docketed April 13, 2023) for authority to 
reorganize and expand under the ASF with a service area of Washington 
County, Maryland, adjacent to the Baltimore Customs and Border 
Protection port of entry, FTZ 255's existing Sites 1, 2, 4, 6 and 7 
would be categorized as magnet sites, and the grantee proposes one 
initial subzone (Subzone 255A);
    Whereas, notice inviting public comment was given in the Federal 
Register (88 FR 24161-24162, April 19, 2023) and the application has 
been processed pursuant to the FTZ Act and the Board's regulations; 
and,
    Whereas, the Board adopts the findings and recommendations of the 
examiners' report, and finds that the requirements of the FTZ Act and 
the Board's regulations are satisfied;
    Now, therefore, the Board hereby orders:
    The application to reorganize and expand FTZ 255 under the ASF is 
approved, subject to the FTZ Act and the Board's regulations, including 
section 400.13, to the Board's standard 2,000-acre activation limit for 
the zone, to an ASF sunset provision for magnet sites that would 
terminate authority for Sites 1, 4, 6 and 7 if not activated within 
five years from the month of approval, and to an ASF sunset provision 
for subzones that would terminate authority for Subzone 255A if no 
foreign-status merchandise is admitted for a bona fide customs purpose 
within three years from the month of approval.

    Dated: October 24, 2023.
Lisa W. Wang,
Assistant Secretary for Enforcement and Compliance, Alternate Chairman, 
Foreign-Trade Zones Board.
[FR Doc. 2023-23851 Filed 10-27-23; 8:45 am]
BILLING CODE 3510-DS-P
Exhibit
23.1




CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 We
consent to the incorporation by reference in Registration Statement No.
333-151391 on Form S-8 of our report dated October 13, 2010, relating to the
consolidated financial statements of SouthPeak Interactive Corporation and
subsidiaries (the “Company”) (which report expresses an unqualified opinion and
includes an explanatory paragraph relating to the existence of substantial doubt
about the Company’s ability to continue as a going concern) appearing in the
Annual Report on Form 10-K of SouthPeak Interactive Corporation for the year
ended June 30, 2010.
 
 /s/
Reznick Group, P.C.
 
 Vienna,
Virginia
 October
13, 2010
Before the Second Division,

August 6, 1951

No. 55801.

protests 772231-G/83708 and 796869-G/83480 (Chicago).

#### Louis Barnett Hat Co., Inc., and Portis Bros. Hat Co. *v.*United States,

Opinion by

Ford, J.

The protests were dismissed.
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1115 Introduced in House (IH)]

106th CONGRESS
  1st Session
                                H. R. 1115

 To amend title XVIII of the Social Security Act to eliminate the time 
 limitation on benefits for immunosuppressive drugs under the Medicare 
                                Program.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 16, 1999

Mr. Canady of Florida (for himself, Mrs. Thurman, Mr. Abercrombie, Mr. 
    Ackerman, Mr. Allen, Mr. Baldacci, Mr. Barrett of Nebraska, Mr. 
    Bentsen, Mr. Boehlert, Mr. Borski, Mr. Boucher, Mr. Coburn, Mr. 
 Cooksey, Mr. Coyne, Mr. Deal of Georgia, Mr. DeFazio, Mr. Engel, Mr. 
English, Mr. Filner, Mr. Foley, Mr. Frank of Massachusetts, Mr. Franks 
 of New Jersey, Mr. Frost, Mr. Gallegly, Mr. Gilchrest, Mr. Goss, Mr. 
   Graham, Mr. Green of Texas, Mr. Gutierrez, Mr. Hall of Ohio, Mr. 
  Hayworth, Mr. Inslee, Mr. Jenkins, Mrs. Johnson of Connecticut, Ms. 
   Kilpatrick, Mr. Kleczka, Mr. Kolbe, Mr. LaFalce, Mr. Matsui, Mr. 
 Mascara, Mr. McCollum, Mr. McGovern, Mr. McHugh, Mrs. Mink of Hawaii, 
  Mr. Moakley, Mrs. Morella, Mr. Nethercutt, Mr. Olver, Mr. Price of 
  North Carolina, Mr. Quinn, Mr. Rahall, Mr. Regula, Mr. Rothman, Mr. 
Rush, Mr. Sanders, Mr. Sandlin, Mr. Shadegg, Mr. Shays, Mr. Shows, Ms. 
    Slaughter, Mr. Smith of New Jersey, Mr. Snyder, Mr. Souder, Ms. 
Stabenow, Mr. Stark, Mr. Tierney, Mr. Towns, Mr. Walsh, Mr. Waxman, Mr. 
  Wexler, Mr. Weygand, Mr. Whitfield, Mrs. Wilson, Mr. Wolf, and Ms. 
   Woolsey) introduced the following bill; which was referred to the 
   Committee on Ways and Means, and in addition to the Committee on 
Commerce, for a period to be subsequently determined by the Speaker, in 
   each case for consideration of such provisions as fall within the 
                jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
 To amend title XVIII of the Social Security Act to eliminate the time 
 limitation on benefits for immunosuppressive drugs under the Medicare 
                                Program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Immunosuppressive Drug Coverage 
Extension Act of 1999''.

SEC. 2. ELIMINATION OF TIME LIMITATION ON MEDICARE BENEFITS FOR 
              IMMUNOSUPPRESSIVE DRUGS.

    (a) In General.--Section 1861(s)(2)(J) of the Social Security Act 
(42 U.S.C. 1395x(s)(2)(J)) is amended by striking ``, but only'' and 
all that follows up to the semicolon at the end.
    (b) Effective Date.--The amendment made by subsection (a) shall 
apply to drugs furnished on or after the date of the enactment of this 
Act.
                                 <all>
```
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies, in his capacity as an officer of Standard Pacific Corp., a Delaware corporation (the Company), for purposes of 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| |  |  | the Companys Quarterly Report on Form 10-Q for the period ended September 30, 2008, as filed with the Securities and Exchange Commission on the date
hereof (the Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------

Dated: November 6, 2008



|                                      
|--------------------------------------
|/s/ Jeffrey V. Peterson               
|Jeffrey V. Peterson                   
|Chairman of the Board of Directors,   
|Chief Executive Officer and President 
|                                      
|/s/ Andrew H. Parnes                  
|Andrew H. Parnes                      
|Executive Vice President  Finance and
|Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                           3,484
<SECURITIES>                                         0
<RECEIVABLES>                                    9,412
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                          56,645
<DEPRECIATION>                                   5,389
<TOTAL-ASSETS>                                  66,193
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        18,102
<OTHER-SE>                                      18,481
<TOTAL-LIABILITY-AND-EQUITY>                    66,193
<SALES>                                          4,250
<TOTAL-REVENUES>                                 6,552
<CGS>                                            2,428
<TOTAL-COSTS>                                    3,042
<OTHER-EXPENSES>                                 1,101
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 516
<INCOME-PRETAX>                                  1,604
<INCOME-TAX>                                       644
<INCOME-CONTINUING>                                960
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       960
<EPS-PRIMARY>                                      .15
<EPS-DILUTED>                                      .15
        

</TABLE>
Exhibit
32.1




CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906


OF
THE SARBANES-OXLEY ACT OF 2002




In
connection with the Annual Report of Universal Travel Group (the “Company”) on
Form 10-K for the period ending December 31, 2009, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Jiangping Jiang,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350,
as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002,
that:





1.
            The
      Report fully complies with the requirements of Sections 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





2.
            The
      information contained in the report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





/s/ Jiangping JiangJiangping
      JiangChief
      Executive Officer
No. 60374.

protest 287353-K (San Francisco).

#### Airgo International Corp. *v.*United States,

Opinion by

Johnson, J.

In accordance with rule 5 (b) of the rules of this court, as amended, effective July 1, 1955, the protest was dismissed for lack of prosecution.
Before the Second Division,

October 9, 1952

No. 56890.

#### Modernophone, Inc., and H. S. Dorf & Co., Inc. *v.*United States,

protests 170455-K, etc. (New York).

*382Opinion by

Rao, J.

At the trial it was stipulated that the merchandise described on the invoices as containers, with or without other words, consists of boxes in chief value of paper, covered with cotton, and a sample of a box-container representative of the involved merchandise was received in evidence as exhibit 1. Upon the record as made, the claim of the plaintiffs was sustained.
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 601 Engrossed in House (EH)]

<DOC>
H. Res. 601

                In the House of Representatives, U. S.,

                                                      November 2, 2017.
    Resolved, That upon adoption of this resolution it shall be in order to 
consider in the House the bill (H.R. 3922) to extend funding for certain public 
health programs, and for other purposes. All points of order against 
consideration of the bill are waived. In lieu of the amendment in the nature of 
a substitute recommended by the Committee on Energy and Commerce now printed in 
the bill, the amendment printed in part A of the report of the Committee on 
Rules accompanying this resolution, modified by the amendment printed in part B 
of that report, shall be considered as adopted. The bill, as amended, shall be 
considered as read. All points of order against provisions in the bill, as 
amended, are waived. The previous question shall be considered as ordered on the 
bill, as amended, and on any further amendment thereto, to final passage without 
intervening motion except: (1) one hour of debate equally divided and controlled 
by the chair and ranking minority member of the Committee on Energy and 
Commerce; and (2) one motion to recommit with or without instructions.
            Attest:

                                                                          Clerk.
```
<PAGE>   1
                                                                     EXHIBIT 3.2

                   AMENDMENT TO THE ARTICLES OF INCORPORATION
                                       OF
                         SUN COMMUNITY BANCORP LIMITED

     The fifth Article of the Articles of Incorporation of Sun Community Bancorp
Limited is hereby amended in its entirety to read as follows:

     V.   AUTHORIZED CAPITAL: The aggregate number of shares which the
corporation shall have authority to issue is 50,000,000 shares of common stock
consisting of one class only. There shall be no par value.
Exhibit 32.1

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual report on Form 10K of ATEL Capital  Equipment Fund
IX, LLC, (the  "Company")  for the period ended  December 31, 2004 as filed with
the Securities and Exchange  Commission on the date hereof (the  "Report"),  and
pursuant  to  18  U.S.C.   ss.1350,   as  adopted  pursuant  to  ss.906  of  the
Sarbanes-Oxley  Act of 2002, I, Dean L. Cash,  Chief  Executive  Officer of ATEL
Financial Services, LLC, managing member of the Company, hereby certify that:

1. The Report fully complies with the  requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

2. The  information  contained in the Report  fairly  presents,  in all material
respects, the financial condition and results of operations of the Company.

Date:        3/29/2005



/s/ Dean L. Cash
-------------------
Dean L. Cash
President and Chief Executive
Officer of Managing Member
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 57 Introduced in House (IH)]

106th CONGRESS
  1st Session
H. J. RES. 57

Disapproving the extension of nondiscriminatory treatment (normal trade 
relations treatment) to the products of the People's Republic of China.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              June 7, 1999

 Mr. Rohrabacher introduced the following joint resolution; which was 
              referred to the Committee on Ways and Means

_______________________________________________________________________

                            JOINT RESOLUTION

 
Disapproving the extension of nondiscriminatory treatment (normal trade 
relations treatment) to the products of the People's Republic of China.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That the Congress does not 
approve the extension of the authority contained in section 402(c) of 
the Trade Act of 1974 recommended by the President to the Congress on 
June 3, 1999, with respect to the People's Republic of China.
                                 <all>
```
No. 58844.

protest 242616-K (New York).

#### Barnett International Forwarders, Inc. *v.*United States,

Opinion by

Wilson, J.

An examination of the official papers failing to disclose any reason for disturbing the action of the collector, which was presumptively correct, the protest was overruled.
Exhibit 32.2


                                RAVEN GOLD CORP.

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Raven Gold Corp. on Form 10-KSB/A for
the year ended April 30, 2007 as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), I, Bashir Virji, Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been
provided to Raven Gold Corp. and will be retained by Raven Gold Corp. and
furnished to the Securities and Exchange Commission or its staff upon request.


                                                   /s/ Bashir Virji
                                                   ----------------
                                                   Bashir Virji
                                                   Chief Financial Officer,
                                                   acting Principal Financial
                                                   Officer and acting
                                                   Principal Accounting Officer
Dated: August 13, 2007
psn-ex1023_1475.htm



Exhibit 10.23

First Amendment to the

 

PARSONS CORPORATION EXECUTIVE RESTORATION PLAN

(As Amended Through January 1, 2013)

The Parsons Corporation Executive Restoration Plan (As Amended Through January 1, 2013) is hereby amended as follows, unless otherwise indicated:


	
 
	
1.
	
Effective January 1, 2020 section 3.1 is hereby amended and restated to read:




Section 3.1. Employer Contributions. The Employer shall credit a percentage of Eligible Compensation to the Account of each Participant whether or not he is actively at work on the Valuation Date; such percentage shall be equal to the percentage in the Plan Year of the Corporation’s contribution to the ESOP.

2.Effective January 1, 2020, section 3.2(b) of the Plan is hereby deleted in its entirety and is hereby amended and restated to provide as follows: 

(b)       Each Account shall be credited with interest equal to the Bank of America prime rate in effect on the Valuation Date, compounded annually.


IN WITNESS WHEREOF, this instrument of amendment is executed this 20th day of January 2020.

PARSONS CORPORATION

By: 

Name: 

Title:
<page>



Exhibit 32.1



                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

        In connection with the amended Quarterly Report of Dragon International
Group Corp. on Form 10-QSB/A1 for the period ending March 31, 2005 as filed
with the Securities and Exchange Commission on the date hereof, I, David Wu,
Chief Executive Officer of the Company,  certify, pursuant to 18 U.S.C.  ss.
1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

     1. The Report complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

     2. The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.


November 15, 2005


                                 By:/s/ David Wu
                                    David Wu, CEO



<page>
<TABLE> <S> <C>

<ARTICLE> 5

<S>                                           <C>
<PERIOD-TYPE>                                3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                             375
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                   375
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                     375
<CURRENT-LIABILITIES>                          890,159
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        11,434
<OTHER-SE>                                   2,359,430
<TOTAL-LIABILITY-AND-EQUITY>                       375
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                17,368
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,352
<INCOME-PRETAX>                               (17,368)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (35,720)
<EPS-BASIC>                                  (0.002)
<EPS-DILUTED>                                        0



</TABLE>
No. 67717.

#### Lanston Industries, Inc., et al. *v.*United States,

protests 62/10455, etc. (Philadelphia).

Opinion by

Eord, J.

In .accordance with stipulation of counsel that the merchandise consists of monophoto machines or parts thereof similar in all material respects to those the subject of *Lanston Industries, Inc.*v. *United States*(49 CCPA 123, C.A.D. 807), the claim of the plaintiffs was sustained.